H.C. Wainwright initiated coverage of Actuate Therapeutics (ACTU) with a Buy rating and $20 price target Actuate is a clinical-stage biotechnology company developing novel glycogen synthase kinase ...

and business acumen all come into play on a regular basis as he helps both executive management and boards of directors develop and actuate corporate-wide strategies while maintaining hands-on ...

At close: March 14 at 4:00:01 PM EDT Loading Chart for ACTU ...

Orange stools can be caused by foods that are orange in color (either natural or artificial color, which tends to last much longer and have deeper color). Orange poop can also happen after taking ...